Article
The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl.
Blood - 15 Apr 2002
He Yiping, Wertheim Jason A, Xu Lanwei, Miller Juli P, Karnell Fredrick G, Choi John K, Ren Ruibao, Pear Warren S
Abstract excerpt
The bcr/abl fusion in chronic myelogenous leukemia (CML) creates a chimeric tyrosine kinase with dramatically different properties than intact c-abl. In P210 bcr/abl, the bcr portion includes a coiled-coil oligomerization domain (amino acids 1-63) and a grb2-binding site at tyrosine 177 (Tyr177) that are critical for fibroblast transformation, but give variable results in other cell lines. To investigate the role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
